$13.76
0.010.07%
Últ. Act.: Oct 21, 4:02 AM
$13.74
-0.01-0.07%
Organon (OGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Organon (OGN) publicó su última previsión de febrero 12, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $6.2B - $6.2B para el período.
En comparación con la previsión anterior, Organon mantenido redujo su previsión de ingresos desde un rango anterior de $6.2B - $6.25B.
Organon ha emitido 15 actualizaciones de orientación entre el noviembre 3, 2022 y el febrero 12, 2026. During this period, the company raised its outlook 3 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.03 | $0.84 | $0.72 | $0.92 |
| Actual | $0.85 | $0.71 | $0.63 | $1.01 |
| Surprise | -17.5% | -15.5% | -12.5% | +9.78% |
| Revenue | ||||
| Estimate | $1.55B | $1.48B | $1.52B | $1.57B |
| Actual | $1.56B | $1.46B | $1.51B | $1.60B |
| Surprise | +0.33% | -1.63% | -1.08% | +1.83% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.90 | $0.81 |
| Revenue | ||
| Consensus | $1.58B | $1.55B |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 31, 2026 | $0.85 | $1.03 | -17.5 % |
| Q1 | Apr 30, 2026 | $0.71 | $0.84 | -15.5 % |
| Q4 | Feb 12, 2026 | $0.63 | $0.72 | -12.5 % |
| Q3 | Nov 10, 2025 | $1.01 | $0.92 | 9.78 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 31, 2026 | $1.56B | $1.55B | 0.33 % |
| Q1 | Apr 30, 2026 | $1.46B | $1.48B | -1.63 % |
| Q4 | Feb 12, 2026 | $1.51B | $1.52B | -1.08 % |
| Q3 | Nov 10, 2025 | $1.60B | $1.57B | 1.83 % |